Akari Therapeutics Plc - American Depositary Shares — Stato Patrimoniale (NASDAQ:AKTX) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 14.6 M11.65 M13.83 M4.36 M50.56 M47.89 M Totale passività 5.22 M6.09 M12.04 M4.58 M28.33 M19.56 M Patrimonio netto totale 9.38 M5.55 M1.79 M-229 K22.23 M28.33 M Totale passività e patrimonio netto 14.6 M11.65 M13.83 M4.36 M50.56 M47.89 M Debito totale ————1.36 M754 K Indebitamento netto ————-1.24 M754 K

Notizie

Akari Therapeutics collabora con WuXi XDC sugli ADC

Upcoming Stock Splits This Week (March 30 to April 2) – Stay Invested - TipRanks.com

Akari Therapeutics modifica il rapporto ADS per rispettare le regole del Nasdaq

Akari Therapeutics celebra un anno con il CEO Gaslightwala

Akari Therapeutics marks one year under CEO Gaslightwala

Akari Therapeutics aggiunge esperto di splicing RNA al comitato consultivo

Akari Therapeutics adds RNA splicing expert to advisory board

Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), Aimei Health Technology (NASDAQ:AFJK)

Akari Therapeutics avanza nel programma oncologico ADC con un nuovo payload

Akari Therapeutics advances ADC oncology program with novel payload

Akari avvia la produzione GMP del programma ADC principale con WuXi XDC

Akari begins GMP manufacturing of lead ADC program with WuXi XDC